TOLFEDINE 4% INJECTABLE SOLUTION DIN 02238924
Health Canada record
| Active ingredient(s) | TOLFENAMIC ACID 40 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 01-Feb-1999 |
| Current status date | 16-Nov-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Vetoquinol N A Inc. — licence 100448, currently licensed, last inspection rating C (2025-10-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TOLFENAMIC ACID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02238077 | TOLFEDINE TABLETS 20MG | VETOQUINOL N A INC | Tablet | TOLFENAMIC ACID 20 MG | Cancelled Post Market |
| 02231279 | TOLFEDINE TABLETS 60MG | VETOQUINOL N A INC | Tablet | TOLFENAMIC ACID 60 MG | Cancelled Post Market |
| 02231278 | TOLFEDINE TABLETS 6MG | VETOQUINOL N A INC | Tablet | TOLFENAMIC ACID 6 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6936 | 1998-10-27 | New Drug Submission (NDS) |
International API supply for TOLFENAMIC ACID
1 valid EDQM Certificates of Suitability from 1 holders. 1 active FDA Drug Master Files.
Request a quote for TOLFEDINE 4% INJECTABLE SOLUTION